Vanderbilt involved in another big pandemic development
Vanderbilt researchers made key discoveries that drove the development of a new antiviral pill for COVID-19 patients.
- Pharmaceutical company Merck last week announced plans to seek authorization for the pill, saying it cut in half the risk of hospitalization or death during a clinical trial.
Why it matters: Vanderbilt University Medical Center emerged as a leading force in the pandemic — with some help from Dolly Parton.
- Continued pandemic successes could spur more funding and high-profile projects for the city's biggest employer.
Details: The antiviral drug is another watershed moment. It was developed in partnership with investigators at Emory University and UNC-Chapel Hill, with subsequent development from Merck and Ridgeback Therapeutics.
- Investigators in VUMC professor Mark Denison's lab found evidence the antiviral, known as molnupiravir, could be effective against COVID.
- Subsequent animal testing showed the drug prevented severe lung damage in infected mice.
Between the lines: Denison told Axios that he and his team had researched coronaviruses for decades.
- His lab was investigating molnupiravir and remdesivir years before they became critical tools against the pandemic. Denison even had to explain and justify his research focus to skeptics.
- "It's not science fiction. You don’t go into a lab and then come out in 24 hours with an answer," Denison said.
- Denison's lab is continuing to examine molnupiravir, remdesivir, and new drugs while also researching the efficacy of different drug combinations.
Context: VUMC has been involved on several fronts in the battle against COVID-19.
- The Vanderbilt Vaccine Research Program oversaw trials for the Moderna and Johnson & Johnson vaccines. Denison's lab also participated in early studies showing the Moderna vaccine worked.
- Earlier this month, VUMC announced researchers discovered a drug used for rheumatoid arthritis had potentially life-saving effects on hospitalized COVID patients.
- AstraZeneca on Tuesday announced plans to seek FDA emergency use authorization for antibodies developed last year at VUMC.
What they're saying: "From conducting vaccine trials, treating COVID patients, advising on health policy, and now helping to develop a COVID pill, VUMC has played a critical role throughout the pandemic," Mayor John Cooper said in a statement to Axios. "Nashville is fortunate to have VUMC in our community."
More Nashville stories
No stories could be found
Get a free daily digest of the most important news in your backyard with Axios Nashville.